Gabapentin Tablet, Coated
Product Images NDC 68071-3783

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68071-3783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3783 9)

Label for Gabapentin 600 mg coated tablets by NuCare Pharmaceuticals, Inc. The package contains 90 tablets. The label includes identifiers like NDC 68071-3783-9, product number P1292090, and indicates the tablets are elliptical, white, and scored. Storage instructions specify controlled temperatures between 68-77°F, with a warning to keep out of reach of children.*

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of gabapentin, showing a cyclohexane ring bonded to an amino group (CH2NH2) and an acetic acid group (CH2CO2H). The structure represents the molecular arrangement of the active ingredient gabapentin.*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3,600 mg/day. The graph shows a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin scores decreasing steadily while placebo scores remain relatively constant.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph displaying mean pain scores over a 7-week period for placebo and two doses of gabapentin (1,800 mg/day and 2,400 mg/day). The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, illustrating decreasing pain scores for both gabapentin doses compared to placebo over time.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart showing two studies comparing placebo (PBO) and gabapentin (GBP) with different dosages. Study 1 compares PBO (12%) to GBP 3,600 mg (29%), while Study 2 compares PBO (14%) to GBP 1,800 mg (32%) and GBP 2,400 mg (34%). Statistical significance is indicated by p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot chart showing percentage difference on the vertical axis and daily dose in milligrams on the horizontal axis. The chart compares three studies labeled as Study a, Study b, and Study c, each represented by distinct markers, across varying daily doses from 600 mg to 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.